Shenzhen YHLO Biotech Co., Ltd. reported earnings results for the half year ended June 30, 2025. For the half year, the company reported sales was CNY 788.88 million compared to CNY 941.19 million a year ago. Revenue was CNY 808.44 million compared to CNY 960.03 million a year ago.
Net income was CNY 26.27 million compared to CNY 173.03 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.3 a year ago.
